Search for: "Ortho-McNeil Pharmaceuticals" Results 161 - 180 of 270
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2014, 9:27 pm by Legal Reader
The companies that share responsibility for the development, manufacture, and promotion of these drugs include (1) Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
8 Jul 2009, 4:52 am
The FDA ordered Ortho-McNeil to include on Levaquin's label a warning about the incidence of those injuries. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Opana (Oxymorphone) – US: Endo files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Ortho Tri-Cyclen Lo (Ethinyl estradiol, norgestimate) – US:Patent infringement complaint filed in New Jersey following a Paragraph IV certification: Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. [read post]
27 Aug 2011, 7:55 pm
Ortho-McNeil Pharm., Inc. [read post]
21 Sep 2010, 12:42 am by admin
TRADEMARK NOTICE: “Levaquin” is a trademark of Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., and Johnson & Johnson Pharmaceutical Research & Development. [read post]
1 Dec 2010, 12:15 am by Kelly
Apotex, Inc (Patently-O) Simcor (Niacin/Simvastatin) – US: Impax Laboratories confirms patent challenge relating to Simcor extended-release tablets (SmartBrief) Taxotere (Docetaxel) – EU: Actavis launches Docetaxel single vial on patent expiry in major European markets (GenericsWeb) Temodar (Temozolide) – US: Cancer Research Technology files patent infringement suit against Accord following Para IV certification filing (Patent Docs) Tri-Cyclen Lo (Norgestimate/ethinyl estradiol)… [read post]
15 Jan 2012, 6:57 am
Ortho-McNeil Neurologics and Noramco, Inc. discovered Topamax in 1979. [read post]
8 Aug 2011, 6:19 am by Ed Wallis
Topamax is a prescription anticonvulsant drug, currently manufactured by Ortho-McNeil Pharmaceutical, a division of pharmaceutical giant Johnson & Johnson. [read post]
13 Jun 2011, 5:32 pm by FDABlog HPM
Paliperidone FDA approved INVEGA on December 19, 2006 under NDA No. 21-999 and granted the sponsor, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
29 Sep 2009, 7:21 am
” The Ortho Evra birth control patch is still available for sale to this day. [read post]
29 Sep 2009, 7:21 am
” The Ortho Evra birth control patch is still available for sale to this day. [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
14 Jul 2010, 6:47 pm by Kelly
Glaxo tries a ‘Linux’ (Spicy IP) TB Alliance and DNDi team up to fight neglected diseases (IP Watch) Australia: Pharmaceuticals extensions and international inequities: H Lundbeck A/S v Alphapharm Pty Ltd, Ortho-McNeil Pharmaceutical, Inc v Lupin Pharmaceuticals, Inc (Patentology) Australia: The ‘morality’ of gene patents (Patentology) Belgium: Antwerp commercial court finds Belgian counterpart of EU patent covering process for… [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
20 Mar 2009, 2:05 am
., 416 F.2d 417, 426 (2d Cir. 1969).District of Columbia: McNeil Pharmaceutical v. [read post]
31 Jan 2015, 8:32 am by Dr. Shezad Malik
Ortho-McNeil Janssen Pharmaceuticals, 120401997, Court of Common Pleas Philadelphia County (Philadelphia). [read post]